BR0008269A - Uso de uma preparação de m. vaccae, e, método para tratamento de infecção viral crÈnica, excluindo infecção por hiv - Google Patents
Uso de uma preparação de m. vaccae, e, método para tratamento de infecção viral crÈnica, excluindo infecção por hivInfo
- Publication number
- BR0008269A BR0008269A BR0008269-4A BR0008269A BR0008269A BR 0008269 A BR0008269 A BR 0008269A BR 0008269 A BR0008269 A BR 0008269A BR 0008269 A BR0008269 A BR 0008269A
- Authority
- BR
- Brazil
- Prior art keywords
- infection
- chronic viral
- vaccae
- treatment
- excluding
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55588—Adjuvants of undefined constitution
- A61K2039/55594—Adjuvants of undefined constitution from bacteria
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Endocrinology (AREA)
- Dermatology (AREA)
- Reproductive Health (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
"USO DE UMA PREPARAçãO DE M. VACCAE, E, MéTODO PARA TRATAMENTO DE INFECçãO VIRAL CRÈNICA, EXCLUINDO INFECçãO POR HIV". A presente invenção provê o uso de preparação de M.vaccae para a fabricação de um medicamento para uso no tratamento de uma infecção viral crónica, excluindo uma infecção por HIV. As infecções virais crónicas incluem infecção por HPV, como infecção por HPV associada com displasia cervical, infecção por virus do herpes, pan-encefalite esclerosante subaguda, e infecção por vírus de hepatite.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9903539.6A GB9903539D0 (en) | 1999-02-16 | 1999-02-16 | Therapy using M.Vaccae |
| PCT/GB2000/000544 WO2000048615A2 (en) | 1999-02-16 | 2000-02-16 | TREATMENT OF CHRONIC VIRAL INFECTIONS WITH $i(M. VACCAE) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0008269A true BR0008269A (pt) | 2001-11-06 |
Family
ID=10847890
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0008269-4A BR0008269A (pt) | 1999-02-16 | 2000-02-16 | Uso de uma preparação de m. vaccae, e, método para tratamento de infecção viral crÈnica, excluindo infecção por hiv |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US6596282B1 (pt) |
| EP (1) | EP1152768B1 (pt) |
| JP (1) | JP2002537266A (pt) |
| KR (1) | KR20010113691A (pt) |
| CN (1) | CN1377274A (pt) |
| AP (1) | AP2001002254A0 (pt) |
| AT (1) | ATE246930T1 (pt) |
| AU (1) | AU766113B2 (pt) |
| BR (1) | BR0008269A (pt) |
| CA (1) | CA2361925A1 (pt) |
| DE (1) | DE60004481T2 (pt) |
| DK (1) | DK1152768T3 (pt) |
| ES (1) | ES2204508T3 (pt) |
| GB (1) | GB9903539D0 (pt) |
| HK (1) | HK1038697B (pt) |
| HU (1) | HUP0105474A3 (pt) |
| ID (1) | ID30441A (pt) |
| MX (1) | MXPA01008243A (pt) |
| NO (1) | NO20013939L (pt) |
| NZ (1) | NZ513320A (pt) |
| PL (1) | PL350577A1 (pt) |
| PT (1) | PT1152768E (pt) |
| RU (1) | RU2001125429A (pt) |
| TR (1) | TR200102388T2 (pt) |
| WO (1) | WO2000048615A2 (pt) |
| ZA (1) | ZA200106248B (pt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0010496D0 (en) * | 2000-04-28 | 2000-06-14 | Stanford Rook Ltd | Treatment of conditions of the central nervous system |
| US20070098746A1 (en) * | 2005-11-02 | 2007-05-03 | Nichols William M | Multi-layered coating technology for taste masking |
| CN111281893B (zh) * | 2020-03-02 | 2021-11-19 | 广西医科大学第一附属医院 | 注射用母牛分枝杆菌在制备用于防治covid-19的药物中的应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8917256D0 (en) | 1989-07-28 | 1989-09-13 | Univ London | Biological preparation and its use |
| GB9219425D0 (en) * | 1992-09-14 | 1992-10-28 | Univ London | Therapeutic agent and its use |
| GB8919321D0 (en) * | 1989-08-25 | 1989-10-11 | Univ London | Treatment of chronic inflammatory conditions |
| ES2104731T3 (es) * | 1990-11-08 | 1997-10-16 | Univ London | Micobacterium utilizado como adyuvante para antigenos. |
| BR9814432A (pt) | 1997-12-23 | 2000-10-10 | Genesis Res & Dev Corp Ltd | Composições derivadas de mycobacterium vaccae e processo para seu uso |
-
1999
- 1999-02-16 GB GBGB9903539.6A patent/GB9903539D0/en not_active Ceased
-
2000
- 2000-02-16 US US09/913,523 patent/US6596282B1/en not_active Expired - Fee Related
- 2000-02-16 PL PL00350577A patent/PL350577A1/xx not_active Application Discontinuation
- 2000-02-16 EP EP00903857A patent/EP1152768B1/en not_active Expired - Lifetime
- 2000-02-16 DE DE60004481T patent/DE60004481T2/de not_active Expired - Fee Related
- 2000-02-16 DK DK00903857T patent/DK1152768T3/da active
- 2000-02-16 WO PCT/GB2000/000544 patent/WO2000048615A2/en not_active Application Discontinuation
- 2000-02-16 JP JP2000599405A patent/JP2002537266A/ja active Pending
- 2000-02-16 CN CN00803475A patent/CN1377274A/zh active Pending
- 2000-02-16 AU AU25611/00A patent/AU766113B2/en not_active Ceased
- 2000-02-16 BR BR0008269-4A patent/BR0008269A/pt not_active IP Right Cessation
- 2000-02-16 AT AT00903857T patent/ATE246930T1/de not_active IP Right Cessation
- 2000-02-16 PT PT00903857T patent/PT1152768E/pt unknown
- 2000-02-16 ES ES00903857T patent/ES2204508T3/es not_active Expired - Lifetime
- 2000-02-16 AP APAP/P/2001/002254A patent/AP2001002254A0/en unknown
- 2000-02-16 MX MXPA01008243A patent/MXPA01008243A/es unknown
- 2000-02-16 HU HU0105474A patent/HUP0105474A3/hu unknown
- 2000-02-16 TR TR2001/02388T patent/TR200102388T2/xx unknown
- 2000-02-16 NZ NZ513320A patent/NZ513320A/en unknown
- 2000-02-16 KR KR1020017010289A patent/KR20010113691A/ko not_active Application Discontinuation
- 2000-02-16 ID IDW00200102000Q patent/ID30441A/id unknown
- 2000-02-16 RU RU2001125429/14A patent/RU2001125429A/ru not_active Application Discontinuation
- 2000-02-16 CA CA002361925A patent/CA2361925A1/en not_active Abandoned
-
2001
- 2001-07-30 ZA ZA200106248A patent/ZA200106248B/en unknown
- 2001-08-14 NO NO20013939A patent/NO20013939L/no not_active Application Discontinuation
-
2002
- 2002-01-14 HK HK02100237.1A patent/HK1038697B/zh not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE60004481D1 (de) | 2003-09-18 |
| DK1152768T3 (da) | 2003-11-24 |
| CA2361925A1 (en) | 2000-08-24 |
| PL350577A1 (en) | 2002-12-30 |
| KR20010113691A (ko) | 2001-12-28 |
| GB9903539D0 (en) | 1999-04-07 |
| JP2002537266A (ja) | 2002-11-05 |
| NO20013939L (no) | 2001-10-04 |
| ES2204508T3 (es) | 2004-05-01 |
| ZA200106248B (en) | 2002-01-23 |
| TR200102388T2 (tr) | 2002-10-21 |
| EP1152768B1 (en) | 2003-08-13 |
| AU2561100A (en) | 2000-09-04 |
| ID30441A (id) | 2001-12-06 |
| AU766113B2 (en) | 2003-10-09 |
| US6596282B1 (en) | 2003-07-22 |
| WO2000048615A3 (en) | 2000-12-14 |
| PT1152768E (pt) | 2003-12-31 |
| NO20013939D0 (no) | 2001-08-14 |
| MXPA01008243A (es) | 2002-08-30 |
| RU2001125429A (ru) | 2003-06-10 |
| AP2001002254A0 (en) | 2001-09-30 |
| ATE246930T1 (de) | 2003-08-15 |
| HUP0105474A3 (en) | 2003-11-28 |
| HUP0105474A2 (hu) | 2002-05-29 |
| WO2000048615A2 (en) | 2000-08-24 |
| NZ513320A (en) | 2004-04-30 |
| HK1038697A1 (en) | 2002-03-28 |
| CN1377274A (zh) | 2002-10-30 |
| EP1152768A2 (en) | 2001-11-14 |
| DE60004481T2 (de) | 2004-06-24 |
| HK1038697B (zh) | 2004-03-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9710355A (pt) | Composição útil para o tratamento de infecções virais em um mamìfero, processo para tratar uma infecção viral em um mamìfero, e, produto medicinal. | |
| BR0111195A (pt) | Uso de b-l-2'-desoxi-nucleosìdeos no tratamento de infecção por vìrus de hepatite delta | |
| WO2003051306A3 (en) | N4-acylcytosine-1,3-dioxolane nucleosides for treatment of viral infections | |
| WO1998001144A2 (en) | Antiviral agents from plant extracts and use for treatment of viral infections | |
| ATE269321T1 (de) | Arzneimittel gegen virale erkrankungen | |
| HUP0003131A2 (hu) | Polietilénglikol/alfa-interferon konjugátumok fertőzés kezelésére | |
| EA200201279A1 (ru) | Способы и композиции для лечения вирусного гепатита c | |
| ATE475423T1 (de) | Immunostimulierende polynukleotide sequenzen zur verwendung bei der verhinderung und behandlung von viralen erkrankungen | |
| CY1105408T1 (el) | Χρησιμοποιηση στελεχων του ιου parapox ovis για την παρασκευη αντιικων φαρμακων και φαρμακων κατα του καρκινου | |
| TW200509961A (en) | Uses of interferons for the treatment of severe acute respiratory syndrome and other viral infections | |
| AR023824A1 (es) | Terapia de hiv combinacion de antagonista ccr5-interferon alfa pegilado. | |
| WO2002034284A3 (en) | Methods of therapy for hiv infection | |
| PT1242119E (pt) | Combinacoes para o tratamento de infeccoes por virus adn incluindo um diuretico de ansa e um glicosido cardiotonico | |
| BRPI0513321A (pt) | vìrus parapox em combinação com outros agentes antivirais para o tratamento de doenças virais | |
| WO2006045616A3 (en) | β-L-N4-HYDROXYCYTOSINE DEOXYNUCLEOSIDES AND THEIR USE AS PHARMACEUTICAL AGENTS IN THE PROPHYLAXIS OR THERAPY OF VIRAL DISEASES | |
| AR022250A1 (es) | Envase farmaceutico de uso para el tratamiento y prevencion de infecciones por el virus de la hepatitis b, procedimiento para el tratamiento de pacientes o pacientes susceptibles en padecer infecciones por el virus de la hepatitis b. | |
| BR0008269A (pt) | Uso de uma preparação de m. vaccae, e, método para tratamento de infecção viral crÈnica, excluindo infecção por hiv | |
| AR005750A1 (es) | Composicion farmaceutica para tratar o prevenir infecciones con zoster en personas infectadas con el virus de varicela zoster y procedimiento para preparar dicha composicion | |
| AR039915A1 (es) | Tratamiento de la hepatitis c en la poblacion asiatica | |
| WO2004033479A3 (en) | Retroyclins: antiviral and antimicrobial peptides | |
| ATE306275T1 (de) | Pharmazeutische zubereitungen zur behandlung von dns viraler infektionen, welche ein schleifendiureticum und lithium enthalten | |
| WO2001066100A3 (en) | Pharmaceutical composition | |
| Siliciano | HARRT for life | |
| Cohen | When HIV and HCV cohabitate | |
| Gonslaves | Throw down your crutches and walk |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A, 6A, 7A E 8A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1925 DE 27/11/2007. |